KIDRON NADAV 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Mar 15, 2023
Insider Transaction Report
Form 4
KIDRON NADAV
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2023-03-14$2.01/sh+100,000$201,000→ 100,000 total(indirect: By wholly-owned corporation)
Holdings
- 1,053,098
Common Stock